Literature DB >> 21564467

Effectiveness of a colonoscopic screening programme in first-degree relatives of patients with colorectal cancer.

J J Puente Gutiérrez1, M A Marín Moreno, J L Domínguez Jiménez, E Bernal Blanco, J M Díaz Iglesias.   

Abstract

AIM: The study aimed to assess the diagnostic yield of a colonoscopy screening programme in first-degree relatives of colorectal cancer (CRC) patients and to identify factors associated with advanced neoplasia.
METHOD: We conducted a cross-sectional study. Individual characteristics, family trees and colonoscopy findings of asymptomatic first-degree relatives of CRC patients were collected. The findings were classified into cancer (invasive carcinoma and/or non-invasive high-grade neoplasia), high-risk adenomas (≥ 10 mm and/or a villous component) and low-risk adenomas (tubular < 10 mm). The dependent variable was the presence of advanced neoplasia, defined as cancer and/or high-risk adenoma.
RESULTS: Two hundred and sixty-three relatives (147 females), 50.0 ± 11.5 (range, 25-75) years of age, agreed to participate out of a total of 618 who were invited (acceptance rate 42.5%). Index cases were diagnosed at 63.8 ± 12.4 (range, 37-88) years of age. The closest familial relationship was parent/offspring in 168 (63.9%) participants and sibling in 95 (36.1%) participants; 14.8% had three or more relatives with CRC/cancer associated with Lynch syndrome, and two or more affected generations were identified in 24.0%. Advanced neoplasia was found in 56 (21.3%) participants. Of these, invasive cancer, non-invasive high-grade neoplasia and high-risk adenomas were detected in five (1.9%), six (2.3%) and 45 (17.1%) participants, respectively. Low-risk adenomas were detected in 20 (7.6%) participants. Male sex (odds ratio, 2.59; P = 0.003) and sibling relationship (odds ratio, 2.74; P = 0.001) were independently associated with advanced neoplasia.
CONCLUSION: We detected advanced neoplasia in a considerable number of participants. Our data support colonoscopy screening in first-degree relatives of patients with CRC at an earlier age than in the medium-risk population. Male sex and sibling relationship were predictors of advanced neoplasia.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2011        PMID: 21564467     DOI: 10.1111/j.1463-1318.2011.02577.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  9 in total

1.  Anti-miRNA-221 sensitizes human colorectal carcinoma cells to radiation by upregulating PTEN.

Authors:  Qi Xue; Kai Sun; Hai-Jun Deng; Shang-Tong Lei; Jing-Qing Dong; Guo-Xin Li
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 2.  Uncovering the barriers to undergoing screening among first degree relatives of colorectal cancer patients: a review of qualitative literature.

Authors:  Ker-Kan Tan; Violeta Lopez; Mee-Lian Wong; Gerald Choon-Huat Koh
Journal:  J Gastrointest Oncol       Date:  2018-06

Review 3.  Familial colorectal cancer: a review.

Authors:  Franco Armelao; Giovanni de Pretis
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

4.  Colorectal Cancer Screening in the Non-Syndromic Familial Risk Population: Is It Time to Revise the Clinical Guidelines?

Authors:  Enrique Quintero; Antonio Z Gimeno-García
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

Review 5.  Familial colorectal cancer screening: When and what to do?

Authors:  Giovanna Del Vecchio Blanco; Omero Alessandro Paoluzi; Pierpaolo Sileri; Piero Rossi; Giuseppe Sica; Francesco Pallone
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

6.  miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1.

Authors:  Li Zheng; Jiangtao Chen; Zhongyong Zhou; Zhikuan He
Journal:  Onco Targets Ther       Date:  2017-02-20       Impact factor: 4.147

7.  22-year longitudinal study of repetitive colonoscopy in patients with a family history of colorectal cancer.

Authors:  J K Randall; C S Good; J M Gilbert
Journal:  Ann R Coll Surg Engl       Date:  2013-11       Impact factor: 1.951

8.  Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening.

Authors:  Olalla Otero-Estévez; Loretta De Chiara; Mar Rodríguez-Girondo; Francisco Javier Rodríguez-Berrocal; Joaquín Cubiella; Inés Castro; Vicent Hernández; Vicenta Soledad Martínez-Zorzano
Journal:  Sci Rep       Date:  2015-08-12       Impact factor: 4.379

9.  Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer.

Authors:  Joaquin Cubiella; Marc Clos-Garcia; Cristina Alonso; Ibon Martinez-Arranz; Miriam Perez-Cormenzana; Ziortza Barrenetxea; Jesus Berganza; Isabel Rodríguez-Llopis; Mauro D'Amato; Luis Bujanda; Marta Diaz-Ondina; Juan M Falcón-Pérez
Journal:  Cancers (Basel)       Date:  2018-09-01       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.